MeMed Ltd

05.12.2018 – 11:01
DTRA Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test and Point-of-Care Platform
Haifa, Israel (ots/PRNewswire) - MeMed's contract with DTRA is expanded to include key verification milestones MeMed today announced DTRA's expanded commitment to their point-of-care immunoassay platform and ground breaking bacterial versus viral host-response test. (Logo: ...
mehr
20.09.2018 – 15:02
MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections
Haifa, Israel (ots/PRNewswire) - Round includes leading international investors, further solidifying MeMed's leadership in host-based diagnostics MeMed today announced the completion of a new round of financing totaling over $70 million, with participation from new and existing investors including Ping An Global ...
mehr